HBIO Earnings

Quarterly EPS
$-1.10
Q3 2024
$0.00
Q4 2024
$-11.42
Q1 2025
$-0.52
Q2 2025
$-0.30
Q3 2025
$-0.23
Q4 2025
$-0.77
Q1 2026
$-0.64
Q2 2026
Latest Revenue22.7M
Latest Net Income-2910000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.6422.7M-2910000+11.1%-23.1%
Q1 2026-$0.7720.8M-3424000-4.7%+93.3%
Q4 2025-$0.2323.7M-2847000-3.3%
Q3 2025-$0.3020.6M-1231000-6.3%+72.7%
Q2 2025-$0.5220.4M-2282000-11.5%+25.7%
Q1 2025-$11.4221.8M-50340000-11.2%-938.2%
Q4 2024$0.0024.6M18.0K-12.8%+100.0%
Q3 2024-$1.1022.0M-4802000-13.4%-266.7%
Q2 2024-$0.7023.1M-2927000
Q1 2024-$1.1024.5M-4694000
Q4 2023-$0.4328.2M-1818000
Q3 2023-$0.3025.4M-1239000
Harvard Bioscience (HBIO) — Earnings